KODA Distribution Group Acquired by Azelis Group

We represented KODA Distribution Group’s Chief Executive Officer in connection with the company’s acquisition by Azelis Group. KODA will become known as Azelis Americas, led by Frank Bergonzi, CEO and President of KODA, who will assume the role as CEO and President of Azelis Americas and will become a member of the Azelis Board of Directors. Azelis Americas will continue to operate in the USA and Canada, using its existing business model and go-to-market strategy. It will maintain its regional brands and specialty chemicals sales to customers via industry verticals, and through dedicated experts.

KODA Distribution Group, a portfolio company of Audax Group, delivers unparalleled technology, products and service through its network of eleven leading specialty chemical industry companies and application laboratories, that service customers in the US and Canada. Apax Partners-backed Azelis is the leading global specialty chemicals distributor providing a diverse range of innovative products and services; with headquarters in Belgium, Azelis has more than 37 facilities in 35 countries.

You Also May Be Interested In:

  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company
  • Representation of Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare consumer benefits platform. In addition to Health Velocity Capital, other participating investors included U.S. Venture Partners, Chicago Ventures, and Epic Ventures

    We advised Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare...
    Client Type: Private Company